The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0040
0.00 (0.00%)
Aug 11, 2026, 12:54 PM AEST

ASX:HPC Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.472.473.24.39.16.13
Revenue Growth
-15.61%-22.88%-25.48%-52.74%48.52%63.10%
Gross Profit
1.361.361.621.94.72.79
Operating Income
-3.15-3.15-4.2-6.87-10.7-6.83
Net Income
-2.86-2.862.67-8.1-10.61-8.95
Earnings Per Share
-0.01-0.010.01-0.04-0.07-0.12
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.121.123.221.844.6910.67
Total Debt
---3.893.71-
Net Cash (Debt)
1.121.123.22-2.050.9810.67
Net Cash Growth
-47.02%-65.22%---90.85%548.95%
Net Cash Per Share
0.000.000.01-0.010.010.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.65-3.65-3.88-5.73-9.75-8.08
Capital Expenditures
------
Free Cash Flow
-3.65-3.65-3.88-5.73-9.75-8.08
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
55.18%55.18%50.58%44.18%51.61%45.53%
Operating Margin
-127.29%-127.29%-130.95%-159.62%-117.60%-111.52%
Pretax Margin
-111.31%-111.31%-177.05%-168.07%-116.56%-146.10%
Profit Margin
-115.75%-115.75%83.23%-188.39%-116.56%-146.10%
FCF Margin
-147.82%-147.82%-121.03%-133.22%-107.16%-131.84%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--1.27---
PS Ratio
0.570.581.061.011.105.73